Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
HKSE:02526'
s FCF Yield % Range Over the Past 10 Years
Min: -0.2 Med: -0.16 Max: -0.11
Current: -0.12
During the past 3 years, the highest FCF Yield % of Hangzhou Diagens Biotechnology Co was -0.11%. The lowest was -0.20%. And the median was -0.16%.
HKSE:02526's FCF Yield % is ranked better than 52.7% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -0.475
vs HKSE:02526: -0.12
Hangzhou Diagens Biotechnology Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hangzhou Diagens Biotechnology Co FCF Yield % Related Terms
Hangzhou Diagens Biotechnology Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Diagens Biotechnology Co FCF Yield % Chart
Hangzhou Diagens Biotechnology Co Annual Data
Trend
Dec23
Dec24
Dec25
FCF Yield %
0.00
0.00
0.00
Hangzhou Diagens Biotechnology Co Quarterly Data
Dec23
Dec24
Sep25
Dec25
Jun26
FCF Yield %
0.00
0.00
0.00
0.00
0.00
HKSE:02526 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Hangzhou Diagens Biotechnology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou Diagens Biotechnology Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou Diagens Biotechnology Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Hangzhou Diagens Biotechnology Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a FCF Yield % of -0.12 as of Aug. 14, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hangzhou Diagens Biotechnology Co and its competitors. According to the industry distribution chart, Hangzhou Diagens Biotechnology Co ranks #403 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 47.3%.
Is Hangzhou Diagens Biotechnology Co's FCF Yield % too high?
Hangzhou Diagens Biotechnology Co's current FCF Yield % is -0.12. Based on the distribution chart, Hangzhou Diagens Biotechnology Co ranks #403 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Hangzhou Diagens Biotechnology Co has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Hangzhou Diagens Biotechnology Co's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou Diagens Biotechnology Co ranks #403 out of 852 companies for FCF Yield %. This puts Hangzhou Diagens Biotechnology Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hangzhou Diagens Biotechnology Co and its competitors. Hangzhou Diagens Biotechnology Co's current FCF Yield % is -0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou Diagens Biotechnology Co stock overvalued right now?
Hangzhou Diagens Biotechnology Co (HKSE:02526) has a current FCF Yield % of -0.12. The current FCF Yield % is -0.12. Hangzhou Diagens Biotechnology Co's overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Hangzhou Diagens Biotechnology Co (HKSE:02526), the current FCF Yield % is -0.12 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hangzhou Diagens Biotechnology Co Ltd and its subsidiaries are involved in the development and commercialisation of medical imaging artificial intelligence technologies and medical imaging equipment. It has self-developed a diversified portfolio, including six medical imaging software products, three commercialized medical devices, four key reagents and consumables and two technology licensing offerings. Its Core Product, AI AutoVision, is an auxiliary diagnostic software designed to undertake intelligent analysis on chromosome karyotyping. The majority of the company's revenue is derived from Technology Licensing, mainly in the Chinese mainland.
8GF Score
Get the complete analysis for HKSE:02526
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02526 has been successfully added to your 
